July 29, 2016 1:38 AM ET

Capital Markets

Company Overview of Fidelity Select Portfolios - Biotechnology Portfolio

Key Executives for Fidelity Select Portfolios - Biotechnology Portfolio

NameBoard RelationshipsTitleAge
Christine Reynolds 47 RelationshipsPresident and Treasurer58
Paul M. Murphy No RelationshipsChief Financial Officer68

Fidelity Select Portfolios - Biotechnology Portfolio Board Members*

NameBoard RelationshipsPrimary CompanyAge
Edward Crosby Johnson III 52 RelationshipsFidelity Employer Services Company, LLC86
Kenneth L. Wolfe 52 RelationshipsFidelity School Street Trust77
William S. Stavropoulos Ph.D. 106 RelationshipsFidelity Devonshire Trust - Fidelity Mid Cap Value Fund77
Cornelia M. Small 47 RelationshipsTeagle Foundation Incorporated, The72
Marie L. Knowles 148 RelationshipsMcKesson Corporation70
View All Board Members

Fidelity Select Portfolios - Biotechnology Portfolio Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
Audit Committee Marie L. Knowles148 Relationships3 Executives
Nominating Committee Ph.D.Robert M. Gates41 Relationships2 Executives
Corporate Governance Committee George H. Heilmeier52 Relationships4 Executives
View Committee Details
*Data is at least as current as the most recent Definitive Proxy.
 

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

CEO COMPENSATION IN THIS INDUSTRY

  Industry Range
Salary
227.6K
Bonus
44.2K
Total Short Term Compensation
271.8K
Salary
500.9K
Bonus
500.0K
Total Short Term Compensation
1.0M
Salary
369.9K
Bonus
1.1M
Total Short Term Compensation
787.6K
Total Value of Options
27.3M
Salary
742.1K
Total Short Term Compensation
742.1K
Salary
433.3K
Bonus
950.0K
Total Short Term Compensation
750.0K
Compensation as of Fiscal Year
Fidelity Select Portfolios - Biotechnology Portfolio CEO Compensation
Industry Average

INDUSTRY EXECUTIVE CHANGES

TRS Investments Limited Announces Board Appointments
July 28, 2016 5:00 AM ET
BlackRock Capital Investment Corporation Announces Board Changes
July 27, 2016 8:32 PM ET
Manning & Napier, Inc. Appoints Beth Galusha as Principal Financial Officer
July 27, 2016 8:31 PM ET
GAIA Infrastructure Capital Limited Announces Resignation of Rb Makhubela as Independent Non-Executive Director, Effective August 31, 2016
July 27, 2016 1:20 PM ET
Templeton Emerging Markets Investment Trust plc Appoints David Graham as Non-Executive Director
July 27, 2016 12:56 PM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Fidelity Select Portfolios - Biotechnology Portfolio, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.